TTLL7 Activators
TTLL7 Activators refer to a specific category of chemical compounds that have gained significance within the realm of molecular biology and cellular research. These activators are instrumental in modulating the activity of the TTLL7 gene, with TTLL7 standing for Tubulin Tyrosine Ligase-Like 7. The TTLL7 gene encodes a protein associated with the post-translational modification of microtubules, an essential component of the cytoskeleton. Microtubules are involved in various cellular processes, including intracellular transport, cell division, and maintenance of cell shape, making TTLL7 Activators a subject of keen interest in elucidating their role in regulating microtubule dynamics.
The mechanism of action of TTLL7 Activators typically involves their interaction with specific regions within the TTLL7 gene, such as its promoter or enhancer sequences. By binding to these regulatory elements, these activators can enhance gene transcription, leading to an increase in the synthesis of the TTLL7 protein. The TTLL7 protein, in turn, is known to play a role in adding tyrosine residues to the microtubules, a crucial modification that affects microtubule stability and function. The precise cellular consequences of TTLL7 activation remain an active area of research, with potential implications for understanding fundamental cellular processes and potentially uncovering novel avenues for further scientific investigation. As researchers continue to explore the functions and downstream effects of TTLL7 Activators, they may contribute to advancing our knowledge of microtubule biology and its impact on cellular dynamics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), which may upregulate TTLL7 as part of a cellular energy homeostasis response, potentially affecting microtubule dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin can affect protein synthesis and autophagy, possibly influencing TTLL7 expression as part of the cellular stress response to altered metabolic states. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
This histone deacetylase inhibitor may increase the accessibility of chromatin and enhance the expression of genes like TTLL7, involved in cytoskeletal regulation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
By inhibiting phosphodiesterases, caffeine increases cAMP levels, which could lead to the activation of transcription factors affecting TTLL7 expression as part of cellular signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
As a proteasome inhibitor, bortezomib may induce a cellular stress response that upregulates TTLL7 expression as part of the attempt to maintain protein homeostasis. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Through its action on cereblon, thalidomide modulates the ubiquitin-proteasome system, potentially affecting the expression of proteins like TTLL7 involved in cytoskeletal dynamics. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
As an endocrine disruptor, Bisphenol A might influence gene expression through estrogen receptor-mediated pathways, potentially affecting genes like TTLL7. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
This compound, known for generating reactive oxygen species (ROS), might induce TTLL7 expression as part of a cellular response to oxidative stress. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As a PPARγ agonist, pioglitazone could modulate the expression of genes involved in energy homeostasis and lipid metabolism, potentially including TTLL7. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Through its action as an inducer of oxidative stress and apoptosis, arsenic trioxide may upregulate TTLL7 as part of the cellular stress response mechanisms. | ||||||